SM

Sridhar Muthuramaswamy

Director DIN 03085440
DIN 03085440 First appointment Jul 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Sridhar Muthuramaswamy

Data last updated:

Sridhar Muthuramaswamy was a Director at Shinto Life Pharmaceuticals Private Limited (from 2011) and Director at Skellys Pharmaceuticals Private Limited (from 2010).

DIN 03085440
First Appointment 19 Jul 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20112010Strike Off
Director19 Jul 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Shinto Life Pharmaceuticals Private Limited
Skellys Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sridhar Muthuramaswamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sridhar Muthuramaswamy

Sridhar Muthuramaswamy was first appointed on 19 Jul 2010 as Director at Skellys Pharmaceuticals Private Limited. The most recent appointment on record is 01 Jul 2011 at Shinto Life Pharmaceuticals Private Limited.

Sridhar Muthuramaswamy held 2 earlier board appointments: Shinto Life Pharmaceuticals Private Limited (Director, from 01 Jul 2011); Skellys Pharmaceuticals Private Limited (Director, from 19 Jul 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available